Literature DB >> 10666276

Disulfide bonds and membrane topology of the vaccinia virus A17L envelope protein.

T Betakova1, B Moss.   

Abstract

The envelope protein encoded by the vaccinia virus A17L open reading frame is essential for virion assembly. Our mutagenesis studies indicated that cysteines 101 and 121 form an intramolecular disulfide bond and that cysteine 178 forms an intermolecular disulfide linking two A17L molecules. This arrangement of disulfide bonds has important implications for the topology of the A17L protein and supports a two-transmembrane model in which cysteines 101 and 121 are intraluminal and cysteine 178 is cytoplasmic. The structure of the A17L protein, however, was not dependent on these disulfide bonds, as a recombinant vaccinia virus with all three cysteine codons mutated to serines retained infectivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666276      PMCID: PMC111727          DOI: 10.1128/jvi.74.5.2438-2442.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Vaccinia as a model for membrane biogenesis.

Authors:  S Dales; E H Mosbach
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

2.  Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2.

Authors:  S Wang; S Shuman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins.

Authors:  S S Whitehead; D E Hruby
Journal:  Virology       Date:  1994-04       Impact factor: 3.616

4.  N-terminal amino acid sequences of vaccinia virus structural proteins.

Authors:  T Takahashi; M Oie; Y Ichihashi
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

5.  Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin.

Authors:  Y Zhang; B Moss
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

6.  Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.

Authors:  P M Grimley; E N Rosenblum; S J Mims; B Moss
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

7.  Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.

Authors:  M Schmelz; B Sodeik; M Ericsson; E J Wolffe; H Shida; G Hiller; G Griffiths
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis.

Authors:  D Rodríguez; M Esteban; J R Rodríguez
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis.

Authors:  P Traktman; A Caligiuri; S A Jesty; K Liu; U Sankar
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  13 in total

Review 1.  Poxvirus membrane biogenesis.

Authors:  Bernard Moss
Journal:  Virology       Date:  2015-02-26       Impact factor: 3.616

2.  Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5.

Authors:  Liliana Maruri-Avidal; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis.

Authors:  Himani Bisht; Andrea S Weisberg; Patricia Szajner; Bernard Moss
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

4.  Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport.

Authors:  Gabriella A Papale; Paul J Hanson; Daisy Sahoo
Journal:  Biochemistry       Date:  2011-06-24       Impact factor: 3.162

5.  Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature.

Authors:  Karl J Erlandson; Himani Bisht; Andrea S Weisberg; Seong-In Hyun; Bryan T Hansen; Elizabeth R Fischer; Jenny E Hinshaw; Bernard Moss
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

6.  Duplication of the A17L locus of vaccinia virus provides an alternate route to rifampin resistance.

Authors:  Karl J Erlandson; Catherine A Cotter; James C Charity; Craig Martens; Elizabeth R Fischer; Stacy M Ricklefs; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

7.  Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Authors:  Da-Rong Wang; Jye-Chian Hsiao; Chien-Hsuan Wong; Guo-Chian Li; Su-Ching Lin; Steve S-F Yu; Wenlung Chen; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

8.  Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.

Authors:  Andrea S Weisberg; Liliana Maruri-Avidal; Himani Bisht; Bryan T Hansen; Cindi L Schwartz; Elizabeth R Fischer; Xiangzhi Meng; Yan Xiang; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

9.  Identification and characterization of three immunodominant structural proteins of fowlpox virus.

Authors:  Denise Boulanger; Philip Green; Brenda Jones; Gwenn Henriquet; Lawrence G Hunt; Stephen M Laidlaw; Paul Monaghan; Michael A Skinner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Functional characterization of the vaccinia virus I5 protein.

Authors:  Bethany Unger; R Jeremy Nichols; Eleni S Stanitsa; Paula Traktman
Journal:  Virol J       Date:  2008-12-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.